Loading...

Ivan Diamond, MD, PhD

TitleProfessor Emeritus
InstitutionUniversity of California San Francisco
DepartmentNeurology
Phone(510)-914-2556
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Diamond I, Yao L. From Ancient Chinese Medicine to a Novel Approach to Treat Cocaine Addiction. CNS Neurol Disord Drug Targets. 2015; 14(6):716-26. PMID: 26022266.
      View in: PubMed
    2. Yao L, Fan P, Arolfo M, Jiang Z, Olive MF, Zablocki J, Sun HL, Chu N, Lee J, Kim HY, Leung K, Shryock J, Blackburn B, Diamond I. Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis. Nat Med. 2010 Sep; 16(9):1024-8. PMID: 20729865.
      View in: PubMed
    3. Casey GP, Roberts JS, Paul D, Diamond I, Gould HJ. Ranolazine attenuation of CFA-induced mechanical hyperalgesia. Pain Med. 2010 Jan; 11(1):119-26. PMID: 20447295.
      View in: PubMed
    4. Gould HJ, Garrett C, Donahue RR, Paul D, Diamond I, Taylor BK. Ranolazine attenuates behavioral signs of neuropathic pain. Behav Pharmacol. 2009 Dec; 20(8):755-8. PMID: 19773645; PMCID: PMC2975014.
    5. Overstreet DH, Knapp DJ, Breese GR, Diamond I. A selective ALDH-2 inhibitor reduces anxiety in rats. Pharmacol Biochem Behav. 2009 Dec; 94(2):255-61. PMID: 19747934; PMCID: PMC2859712.
    6. Arolfo MP, Overstreet DH, Yao L, Fan P, Lawrence AJ, Tao G, Keung WM, Vallee BL, Olive MF, Gass JT, Rubin E, Anni H, Hodge CW, Besheer J, Zablocki J, Leung K, Blackburn BK, Lange LG, Diamond I. Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res. 2009 Nov; 33(11):1935-44. PMID: 19673742.
      View in: PubMed
    7. Fan P, Jiang Z, Diamond I, Yao L. Up-regulation of AGS3 during morphine withdrawal promotes cAMP superactivation via adenylyl cyclase 5 and 7 in rat nucleus accumbens/striatal neurons. Mol Pharmacol. 2009 Sep; 76(3):526-33. PMID: 19549762; PMCID: PMC2730385.
    8. Bowers MS, Hopf FW, Chou JK, Guillory AM, Chang SJ, Janak PH, Bonci A, Diamond I. Nucleus accumbens AGS3 expression drives ethanol seeking through G betagamma. Proc Natl Acad Sci U S A. 2008 Aug 26; 105(34):12533-8. PMID: 18719114; PMCID: PMC2527946.
    9. Yao L, Fan P, Jiang Z, Gordon A, Mochly-Rosen D, Diamond I. Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways. Mol Pharmacol. 2008 Apr; 73(4):1105-12. PMID: 18202306; PMCID: PMC2692587.
    10. Ferré S, Diamond I, Goldberg SR, Yao L, Hourani SM, Huang ZL, Urade Y, Kitchen I. Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog Neurobiol. 2007 Dec; 83(5):332-47. PMID: 17532111.
      View in: PubMed
    11. Inoue Y, Yao L, Hopf FW, Fan P, Jiang Z, Bonci A, Diamond I. Nicotine and ethanol activate protein kinase A synergistically via G(i) betagamma subunits in nucleus accumbens/ventral tegmental cocultures: the role of dopamine D(1)/D(2) and adenosine A(2A) receptors. J Pharmacol Exp Ther. 2007 Jul; 322(1):23-9. PMID: 17468300.
      View in: PubMed
    12. Yang M, Soohoo D, Soelaiman S, Kalla R, Zablocki J, Chu N, Leung K, Yao L, Diamond I, Belardinelli L, Shryock JC. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists. Naunyn Schmiedebergs Arch Pharmacol. 2007 Apr; 375(2):133-44. PMID: 17310264.
      View in: PubMed
    13. Asyyed A, Storm D, Diamond I. Ethanol activates cAMP response element-mediated gene expression in select regions of the mouse brain. Brain Res. 2006 Aug 23; 1106(1):63-71. PMID: 16854384.
      View in: PubMed
    14. Yao L, McFarland K, Fan P, Jiang Z, Ueda T, Diamond I. Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc Natl Acad Sci U S A. 2006 May 16; 103(20):7877-82. PMID: 16684876; PMCID: PMC1458620.
    15. Yao L, McFarland K, Fan P, Jiang Z, Inoue Y, Diamond I. Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior. Proc Natl Acad Sci U S A. 2005 Jun 14; 102(24):8746-51. PMID: 15937104; PMCID: PMC1142483.
    16. Hopf FW, Mailliard WS, Gonzalez GF, Diamond I, Bonci A. Atypical protein kinase C is a novel mediator of dopamine-enhanced firing in nucleus accumbens neurons. J Neurosci. 2005 Jan 26; 25(4):985-9. PMID: 15673680.
      View in: PubMed
    17. Arolfo MP, Yao L, Gordon AS, Diamond I, Janak PH. Ethanol operant self-administration in rats is regulated by adenosine A2 receptors. Alcohol Clin Exp Res. 2004 Sep; 28(9):1308-16. PMID: 15365300.
      View in: PubMed
    18. Constantinescu A, Wu M, Asher O, Diamond I. cAMP-dependent protein kinase type I regulates ethanol-induced cAMP response element-mediated gene expression via activation of CREB-binding protein and inhibition of MAPK. J Biol Chem. 2004 Oct 08; 279(41):43321-9. PMID: 15299023.
      View in: PubMed
    19. Diamond I. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial. Alcohol Clin Exp Res. 2004 Aug; 28(8):1273. PMID: 15318128.
      View in: PubMed
    20. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, Bonci A, Messing RO. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci. 2004 Aug; 7(8):855-61. PMID: 15258586.
      View in: PubMed
    21. Souroujon MC, Yao L, Chen H, Endemann G, Khaner H, Geeraert V, Schechtman D, Gordon AS, Diamond I, Mochly-Rosen D. State-specific monoclonal antibodies identify an intermediate state in epsilon protein kinase C activation. J Biol Chem. 2004 Apr 23; 279(17):17617-24. PMID: 14761958.
      View in: PubMed
    22. Mailliard WS, Diamond I. Recent advances in the neurobiology of alcoholism: the role of adenosine. Pharmacol Ther. 2004 Jan; 101(1):39-46. PMID: 14729391.
      View in: PubMed
    23. Yao L, Fan P, Jiang Z, Mailliard WS, Gordon AS, Diamond I. Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14379-84. PMID: 14605213; PMCID: PMC283600.
    24. Hopf FW, Cascini MG, Gordon AS, Diamond I, Bonci A. Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. J Neurosci. 2003 Jun 15; 23(12):5079-87. PMID: 12832531.
      View in: PubMed
    25. Borenstein S, Diamond IR, Grant DR, Greig PD, Jones N, Ng V, Roberts E, Fecteau A. Outcome of pediatric live-donor liver transplantation-the Toronto experience. J Pediatr Surg. 2003 May; 38(5):668-71. PMID: 12720166.
      View in: PubMed
    26. Miyamae M, Domae N, Zhou HZ, Sugioka S, Diamond I, Figueredo VM. Phospholipase C activation is required for cardioprotection by ethanol consumption. Exp Clin Cardiol. 2003; 8(4):184-8. PMID: 19649218; PMCID: PMC2719158.
    27. Yao L, Arolfo MP, Dohrman DP, Jiang Z, Fan P, Fuchs S, Janak PH, Gordon AS, Diamond I. betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell. 2002 Jun 14; 109(6):733-43. PMID: 12086672.
      View in: PubMed
    28. Asher O, Cunningham TD, Yao L, Gordon AS, Diamond I. Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase. J Pharmacol Exp Ther. 2002 Apr; 301(1):66-70. PMID: 11907158.
      View in: PubMed
    29. Constantinescu A, Gordon AS, Diamond I. cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression: implications for neuronal responses to ethanol. J Biol Chem. 2002 May 24; 277(21):18810-6. PMID: 11886856.
      View in: PubMed
    30. Dohrman DP, Chen HM, Gordon AS, Diamond I. Ethanol-induced translocation of protein kinase A occurs in two phases: control by different molecular mechanisms. Alcohol Clin Exp Res. 2002 Mar; 26(3):407-15. PMID: 11923596.
      View in: PubMed
    31. Figueredo VM, Diamond I, Zhou HZ, Camacho SA. Chronic dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury. Am J Physiol. 1999 Nov; 277(5 Pt 2):H2091-7. PMID: 10564165.
      View in: PubMed
    32. Diamond I, Gordon AS. The role of adenosine in mediating cellular and molecular responses to ethanol. EXS. 1994; 71:175-83. PMID: 8032148.
      View in: PubMed
    33. Nagy LE, Diamond I, Collier K, Lopez L, Ullman B, Gordon AS. Adenosine is required for ethanol-induced heterologous desensitization. Mol Pharmacol. 1989 Nov; 36(5):744-8. PMID: 2555672.
      View in: PubMed
    34. Diamond I. Alcoholic myopathy and cardiomyopathy. N Engl J Med. 1989 Feb 16; 320(7):458-60. PMID: 2913510.
      View in: PubMed
    35. Diamond I. Studies of acute and chronic effects of ethanol on early evoked potentials. Alcohol. 1987 Jul-Aug; 4(4):255-6. PMID: 3620093.
      View in: PubMed
    36. Diamond I, Wrubel B, Estrin W, Gordon A. Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients. Proc Natl Acad Sci U S A. 1987 Mar; 84(5):1413-6. PMID: 3029780; PMCID: PMC304440.
    37. Gordon AS, Wrubel B, Collier K, Estrin W, Diamond I. Adaptation to ethanol in cultured neural cells and human lymphocytes from alcoholics. Ann N Y Acad Sci. 1987; 492:367-74. PMID: 3037965.
      View in: PubMed
    38. Messing RO, Carpenter CL, Diamond I, Greenberg DA. Ethanol regulates calcium channels in clonal neural cells. Proc Natl Acad Sci U S A. 1986 Aug; 83(16):6213-5. PMID: 2426713; PMCID: PMC386470.
    39. Gordon AS, Collier K, Diamond I. Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol. Proc Natl Acad Sci U S A. 1986 Apr; 83(7):2105-8. PMID: 3008152; PMCID: PMC323239.
    40. Charness ME, Querimit LA, Diamond I. Ethanol increases the expression of functional delta-opioid receptors in neuroblastoma x glioma NG108-15 hybrid cells. J Biol Chem. 1986 Mar 05; 261(7):3164-9. PMID: 3005282.
      View in: PubMed
    41. Gordon AS, Diamond I. Phosphorylation of the nicotinic acetylcholine receptor. Prog Brain Res. 1986; 69:141-7. PMID: 3447229.
      View in: PubMed
    42. Magilen G, Ziskind-Conhaim L, Diamond I, Gordon AS. Irreversible inhibition of phospholipid methylation and protein carboxymethylation does not alter acetylcholine receptor function in muscle cells. Exp Neurol. 1984 Nov; 86(2):198-207. PMID: 6489494.
      View in: PubMed
    43. Greenberg DA, Cooper EC, Gordon A, Diamond I. Ethanol and the gamma-aminobutyric acid-benzodiazepine receptor complex. J Neurochem. 1984 Apr; 42(4):1062-8. PMID: 6321657.
      View in: PubMed
    44. Lo W, Packman S, Nash S, Schmidt K, Ireland S, Diamond I, Ng W, Donnell G. Curious neurologic sequelae in galactosemia. Pediatrics. 1984 Mar; 73(3):309-12. PMID: 6701054.
      View in: PubMed
    45. Charness ME, Gordon AS, Diamond I. Interaction of ethanol with neural cells in culture: a model of intoxication, tolerance and withdrawal. Ciba Found Symp. 1984; 105:73-84. PMID: 6563992.
      View in: PubMed
    46. Charness ME, Gordon AS, Diamond I. Ethanol modulation of opiate receptors in cultured neural cells. Science. 1983 Dec 16; 222(4629):1246-8. PMID: 6316506.
      View in: PubMed
    47. Gordon AS, Milfay D, Diamond I. Identification of a molecular weight 43,000 protein kinase in acetylcholine receptor-enriched membranes. Proc Natl Acad Sci U S A. 1983 Oct; 80(19):5862-5. PMID: 6577458; PMCID: PMC390175.
    48. Koch TK, Gordon AS, Diamond I. Phospholipid methylation in myogenic cells. Biochem Biophys Res Commun. 1983 Jul 18; 114(1):339-47. PMID: 6882429.
      View in: PubMed
    49. Davis CG, Hestrin S, Landahl H, Gordon AS, Diamond I, Korenbrot JI. Activation of acetylcholine receptors causes the partition of hydrophobic cations into postsynaptic membrane vesicles. Nature. 1983 Apr 07; 302(5908):525-8. PMID: 6835384.
      View in: PubMed
    50. Davis CG, Gordon AS, Diamond I. Specificity and localization of the acetylcholine receptor kinase. Proc Natl Acad Sci U S A. 1982 Jun; 79(11):3666-70. PMID: 6954509; PMCID: PMC346484.
    51. Magilen G, Gordon A, Au A, Diamond I. Identification of a mitochondrial phosphoprotein in brain synaptic membrane preparations. J Neurochem. 1981 May; 36(5):1861-4. PMID: 6787174.
      View in: PubMed
    52. Thomas RA, Gordon AS, Diamond I. Phosphoprotein phosphatase activity in normal and dystonic human fibroblast plasma membranes. Proc Soc Exp Biol Med. 1981 Mar; 166(3):405-12. PMID: 6259646.
      View in: PubMed
    53. Gordon AS, Davis CG, Milfay D, Kaur J, Diamond I. Membrane-bound protein kinase activity in acetylcholine receptor-enriched membranes. Biochim Biophys Acta. 1980 Aug 04; 600(2):421-31. PMID: 6250598.
      View in: PubMed
    54. Gordon AS, Diamond I. Regulation of acetylcholine receptor phosphorylation. Adv Biochem Psychopharmacol. 1980; 21:117-24. PMID: 6246736.
      View in: PubMed
    55. Gordon AS, Diamond I. Reversible phosphorylation of the membrane-bound acetylcholine receptor. J Supramol Struct. 1980; 14(2):163-74. PMID: 6262575.
      View in: PubMed
    56. Gordon AS, Guillory RJ, Diamond I, Hucho F. ATP-binding proteins in acetylcholine receptor-enriched membranes. FEBS Lett. 1979 Dec 01; 108(1):37-9. PMID: 520560.
      View in: PubMed
    57. Schmidley J, Sander J, Diamond I, Fishman RA. Dangers of mannitol in treatment of Reye's syndrome. N Engl J Med. 1979 Jul 12; 301(2):106-7. PMID: 449934.
      View in: PubMed
    58. Gordon AS, Milfay D, Davis CG, Diamond I. Protein phosphatase activity in acetylcholine receptor-enriched membranes. Biochem Biophys Res Commun. 1979 Apr 13; 87(3):876-83. PMID: 36894.
      View in: PubMed
    59. Gordon AS, Milfay D, Diamond I. Phosphorylation of the membrane-bound acetylcholine receptor: inhibition by diphenylhydantoin. Ann Neurol. 1979 Feb; 5(2):201-3. PMID: 426485.
      View in: PubMed
    60. Bornstein JC, Pickett JB, Diamond I. Inhibition of the evoked release of acetylcholine by the porphyrin precursor delta-aminolevulinic acid. Ann Neurol. 1979 Jan; 5(1):94-6. PMID: 218495.
      View in: PubMed
    61. Gordon AS, Diamond I. Phosphorylation of the acetylcholine receptor. Adv Exp Med Biol. 1979; 116:175-98. PMID: 224669.
      View in: PubMed
    62. Schneider JA, Diamond I, Rozengurt E. Glycolysis of quiescent cultures of 3T3 cells. Addition of serum, epidermal growth factor, and insulin increases the activity of phosphofructokinase in a protein synthesis-independent manner. J Biol Chem. 1978 Feb 10; 253(3):872-7. PMID: 146038.
      View in: PubMed
    63. Diamond I, Legg A, Schneider JA, Rozengurt E. Glycolysis in quiescent cultures of 3T3 cells. Stimulation by serum, epidermal growth factor, and insulin in intact cells and persistence of the stimulation after cell homogenization. J Biol Chem. 1978 Feb 10; 253(3):866-71. PMID: 304448.
      View in: PubMed
    64. Rozengurt E, Schneider JA, Diamond I, Legg A. The high rate of aerobic glycolysis of transformed 3T3 cells persists after cell homogenization. Biochem Biophys Res Commun. 1977 Sep 09; 78(1):83-90. PMID: 199175.
      View in: PubMed
    65. Gordon AS, Davis CG, Milfay D, Diamond I. Phosphorylation of acetylcholine receptor by endogenous membrane protein kinase in receptor-enriched membranes of Torpedo californica. Nature. 1977 Jun 09; 267(5611):539-40. PMID: 876372.
      View in: PubMed
    66. Simon K, Chaplin ER, Diamond I. Separation of lactate dehydrogenase isoenzymes in rat brain by acrylamide--gel electrophoresis. Anal Biochem. 1977 May 01; 79(1-2):571-4. PMID: 869193.
      View in: PubMed
    67. Goldstein GW, Csejtey J, Diamond I. Carrier mediated glucose transport in capillaries isolated from rat brain. J Neurochem. 1977 Apr; 28(4):725-8. PMID: 894281.
      View in: PubMed
    68. Diamond I, Granelli SG, McDonagh AF. Photochemotherapy and photodynamic toxicity: simple methods for identifying potentially active agents. Biochem Med. 1977 Apr; 17(2):121-7. PMID: 558753.
      View in: PubMed
    69. Gordon AS, Davis CG, Diamond I. Phosphorylation of membrane proteins at a cholinergic synapse. Proc Natl Acad Sci U S A. 1977 Jan; 74(1):263-7. PMID: 264679; PMCID: PMC393239.
    70. Chaplin ER, Goldberg AL, Diamond I. Leucine oxidation in brain slices and nerve endings. J Neurochem. 1976 Apr; 26(4):701-7. PMID: 965962.
      View in: PubMed
    71. Goldstein GW, Wolinsky JS, Csejtey J, Diamond I. Isolation of metabolically active capillaries from rat brain. J Neurochem. 1975 Nov; 25(5):715-7. PMID: 1194927.
      View in: PubMed
    72. Granelli SG, Diamond I, McDonagh AF, Wilson CB, Nielsen SL. Photochemotherapy of glioma cells by visible light and hematoporphyrin. Cancer Res. 1975 Sep; 35(9):2567-70. PMID: 1149051.
      View in: PubMed
    73. Openshaw H, Diamond I. Extraction of D-beta-hydroxybutyrate by brain in diabetic rats. Arch Neurol. 1975 Sep; 32(9):640-1. PMID: 126053.
      View in: PubMed
    74. Griffiths WC, Diamond I, Dextraze P. The albumin binding of unconjugated bilirubin in serum. Clin Biochem. 1975 Aug; 8(4):254-60. PMID: 1157293.
      View in: PubMed
    75. Diamond I, Granelli SG, McDonagh SF, Crafts D, Wilson CB. Photodynamic therapy of experimental gliomas. Trans Am Neurol Assoc. 1975; 100:185-7. PMID: 1226605.
      View in: PubMed
    76. Goldstein GW, Asbury AK, Diamond I. Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries. Arch Neurol. 1974 Dec; 31(6):382-9. PMID: 4216346.
      View in: PubMed
    77. Goldstein GW, Diamond I. Metabolic basis of lead encephalopathy. Res Publ Assoc Res Nerv Ment Dis. 1974; 53:293-304. PMID: 4280106.
      View in: PubMed
    78. Diamond I, Franklin GM, Milfay D. The relationship of choline acetyltransferase activity at the neuromuscular junction to changes in muscle mass and function. J Physiol. 1974 Jan; 236(1):247-57. PMID: 4818500; PMCID: PMC1350837.
    79. Diamond I, Fishman RA. Development of Na+-stimulated glucose oxidation in synaptosomes. J Neurochem. 1973 Nov; 21(5):1043-50. PMID: 4761694.
      View in: PubMed
    80. Diamond I, Fishman RA. Preferential phosphorylation of recently transported 2-deoxy-D-glucose in isolated nerve endings. Brain Res. 1973 Jul 16; 57(1):239-43. PMID: 4716757.
      View in: PubMed
    81. Diamond I, Fishman RA. Development of glucose oxidation in isolated nerve endings. Nature. 1973 Jun 29; 243(5409):519-20. PMID: 4270335.
      View in: PubMed
    82. Diamond I, Fishman RA. High-affinity transport and phosphorylation of 2-deoxy-D-glucose in synaptosomes. J Neurochem. 1973 Jun; 20(6):1533-42. PMID: 4719311.
      View in: PubMed
    83. Diamond I, Granelli SG, McDonagh AF, Nielsen S, Wilson CB, Jaenicke R. Photodynamic therapy of malignant tumours. Lancet. 1972 Dec 02; 2(7788):1175-7. PMID: 4117595.
      View in: PubMed
    84. Yatsu FM, Diamond I, Graziano C, Lindquist P. Experimental brain ischemia: protection from irreversible damage with a rapid-acting barbiturate (methohexital). Stroke. 1972 Nov-Dec; 3(6):726-32. PMID: 4639103.
      View in: PubMed
    85. Roost KT, Pimstone NR, Diamond I, Schmid R. The formation of cerebrospinal fluid xanthochromia after subarachnoid hemorrhage. Enzymatic conversion of hemoglobin to bilirubin by the arachnoid and choroid plexus. Neurology. 1972 Sep; 22(9):973-7. PMID: 4673383.
      View in: PubMed
    86. Diamond I, Milfay D. Uptake of ( 3 H-methyl)choline by microsomal, synaptosomal, mitochondrial and synaptic vesicle fractions of rat brain. The effects of hemicholinium. J Neurochem. 1972 Aug; 19(8):1899-909. PMID: 5047852.
      View in: PubMed
    87. Diamond I, Goldberg AL. Uptake and release of 45Ca by brain microsomes, synaptosomes and synaptic vesicles. J Neurochem. 1971 Aug; 18(8):1419-31. PMID: 4328512.
      View in: PubMed
    88. Diamond I. Choline metabolism in brain. The role of choline transport and the effects of phenobarbital. Arch Neurol. 1971 Apr; 24(4):333-9. PMID: 5548453.
      View in: PubMed
    89. Diamond IF. Studies on the neurotoxicity of bilirubin and the distribution of its derivatives. Birth Defects Orig Artic Ser. 1970 Jun; 6(2):124-7. PMID: 5535456.
      View in: PubMed
    90. Diamond I. Choline metabolism in the central nervous system: the role of choline transport from plasma to brain. Neurology. 1970 Apr; 20(4):382. PMID: 5534994.
      View in: PubMed
    91. Diamond I, Kennedy EP. Carrier-mediated transport of choline into synaptic nerve endings. J Biol Chem. 1969 Jun 25; 244(12):3258-63. PMID: 5797515.
      View in: PubMed
    92. Diamond I. Bilirubin binding and kernicterus. Adv Pediatr. 1969; 16:99-119. PMID: 4899063.
      View in: PubMed
    93. Diamond I, Kennedy EP. A sensitive radiochemical assay for choline acetylase. Anal Biochem. 1968 Jul; 24(1):90-5. PMID: 5665202.
      View in: PubMed
    94. Diamond I, Schmid R. Neonatal hyperbilirubinemia and kernicterus. Experimental support for treatment by exposure to visible light. Arch Neurol. 1968 Jun; 18(6):699-702. PMID: 5690104.
      View in: PubMed
    95. Diamond I, Lucey J, Schmid R. Prevention of hyperbilirubinemia and kernicterus by exposure to light: studies in newborn guinea pigs and premature infants. Trans Am Neurol Assoc. 1968; 93:70-4. PMID: 5711055.
      View in: PubMed
    96. Diamond I, Schmid R. Oxidative phosphorylation in experimental bilirubin encephalopathy. Science. 1967 Mar 10; 155(3767):1288-9. PMID: 6018655.
      View in: PubMed
    97. Diamond I, Odell GB, Johnson L, Boggs TR, Lucey JF. Kernicterus: revised concepts of pathogenesis and management. Pediatrics. 1966 Oct; 38(4):539-46. PMID: 5922172.
      View in: PubMed
    98. Diamond I. Bilirubin encephalopathy: experimental models in newborn and adult animals. Proc Inst Med Chic. 1966 May; 26(3):47-8. PMID: 5936505.
      View in: PubMed
    99. Diamond I, Schmid R. Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system. J Clin Invest. 1966 May; 45(5):678-89. PMID: 5949114; PMCID: PMC292745.
    100. Schmid R, Diamond I, Hammaker L, Gundersen CB. Interaction of bilirubin with albumin. Nature. 1965 Jun 05; 206(988):1041-3. PMID: 5839057.
      View in: PubMed
    101. DIAMOND I, AQUINO TI. MYOGLOBINURIA FOLLOWING UNILATERAL STATUS EPILEPTICUS AND IPSILATERAL RHABDOMYOLYSIS: A CLINICOPATHOLOGICAL REPORT. N Engl J Med. 1965 Apr 22; 272:834-7. PMID: 14267988.
      View in: PubMed
    102. Diamond I, Schmid R. The pathogenesis of bilirubin encephalopathy: experimental models in newborn and adult animals. Trans Am Neurol Assoc. 1965; 90:38-41. PMID: 5857773.
      View in: PubMed